Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



PFIZER INC. Hits QuantWave Price Target Forecast with 14.45% Profit

December 14, 2022
On August 23, 2022, QuantWave issued a long forecast signal for PFIZER INC. with a price of $41.42. After months of market analysis and monitoring, the target was reached on December 14, 2022, at a price of $47.41, offering an impressive profit of 14.45% to investors who acted on the prediction.

Several factors contributed to this achievement, including positive developments in Pfizer's pipeline of pharmaceutical products, strong financial performance, and favorable market conditions. The successful forecast demonstrates the accuracy and reliability of QuantWave's predictive analytics in identifying profitable trading opportunities.

QuantWave is an automated forecasting platform that provides users with access to predictions for a wide range of stocks, enabling investors to capitalize on potential market movements. For those interested in delving deeper into QuantWave's investment strategy, QuantSchool offers comprehensive educational resources on utilizing the forecasting system effectively, guiding investors on generating consistent income through informed decision-making.

Find out how the PFIZER INC. rate is expected to change

Get Forecast for PFE
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for PFE

PFEJune 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments  ~1 min.

Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....

PFEApril 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis  ~1 min.

PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....

PFEApril 3, 2025PFIZER INC. Hits Price Target Forecast with 7.05% Profit  ~1 min.

QuantWave's forecast for PFIZER INC. proved to be successful as the stock reached the predicted target price of 23.84 $ on April 3, 2025, from the initial signal date of May 7, 2024, when the price was at 25....

PFEMarch 27, 2025With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing  ~1 min.

Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership....

PFEMarch 21, 2025Analyst Says Pfizer PFE Stock Will Move Too Fast to Catch  ~1 min.

According to recent analysis by Stocks Prognosis, Pfizer Inc. (NYSE:PFE) is expected to experience significant movement in its stock price in the near future....



Related news

REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 18.25% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved to be highly accurate, as the stock reached the predicted target price of 1172.09 $ on August 15, 2024, from the signal price of 991....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....

REGNAugust 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin  ~1 min.

On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with a Profit of 17.63%  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock successfully reached the price target forecasted by QuantWave on April 4, 2025. The forecast signal was given on February 4, 2025, at a price of 695....

VRTXJuly 30, 2024QuantWave Achieves 17.27% Profit Target for VERTEX PHARMACEUTICALS INCORPORATED  ~1 min.

QuantWave, the automated forecasting platform, has successfully hit its price target forecast for VERTEX PHARMACEUTICALS INCORPORATED, resulting in a profitable return of 17.27%....